IPCA Laboratories Ltd
NSE:IPCALAB

Watchlist Manager
IPCA Laboratories Ltd Logo
IPCA Laboratories Ltd
NSE:IPCALAB
Watchlist
Price: 1 536.65 INR 2.11% Market Closed
Market Cap: 389.9B INR
Have any thoughts about
IPCA Laboratories Ltd?
Write Note

Relative Value

The Relative Value of one IPCALAB stock under the Base Case scenario is 1 777.75 INR. Compared to the current market price of 1 536.65 INR, IPCA Laboratories Ltd is Undervalued by 14%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IPCALAB Relative Value
Base Case
1 777.75 INR
Undervaluation 14%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
17
vs Industry
31
Median 3Y
4
Median 5Y
4.1
Industry
2.6
Forward
4.2
vs History
1
vs Industry
7
Median 3Y
40.8
Median 5Y
31.6
Industry
23
Forward
42.7
vs History
6
vs Industry
15
Median 3Y
30.4
Median 5Y
28.8
Industry
17.8
vs History
1
vs Industry
3
Median 3Y
33.6
Median 5Y
39.6
Industry
25.4
vs History
11
vs Industry
15
Median 3Y
4.6
Median 5Y
4.8
Industry
2.2
vs History
12
vs Industry
30
Median 3Y
3.9
Median 5Y
4.1
Industry
2.8
Forward
4.3
vs History
17
vs Industry
35
Median 3Y
6.1
Median 5Y
6.4
Industry
5.4
vs History
1
vs Industry
16
Median 3Y
21.3
Median 5Y
20.1
Industry
13.7
Forward
22.8
vs History
1
vs Industry
13
Median 3Y
27.5
Median 5Y
24.1
Industry
17.2
Forward
29.6
vs History
6
vs Industry
14
Median 3Y
29.1
Median 5Y
28.1
Industry
16.5
vs History
39
vs Industry
9
Median 3Y
65.6
Median 5Y
62.8
Industry
19.3
vs History
44
vs Industry
25
Median 3Y
3.6
Median 5Y
3.9
Industry
2

Multiples Across Competitors

IPCALAB Competitors Multiples
IPCA Laboratories Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
IPCA Laboratories Ltd
NSE:IPCALAB
389.9B INR 4.7 67.6 28.7 38.7
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
761.8B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
368.4B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.9B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.8B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
158.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
IN
IPCA Laboratories Ltd
NSE:IPCALAB
Average P/E: 37.6
67.6
169%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.6
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.3
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top